Short Interest in BIO-key International Inc. (NASDAQ:BKYI) Drops By 78.5%

BIO-key International Inc. (NASDAQ:BKYI) saw a significant decline in short interest in the month of August. As of August 14th, there was short interest totaling 13,765 shares, a decline of 78.5% from the July 30th total of 63,876 shares. Based on an average daily volume of 111,165 shares, the short-interest ratio is presently 0.1 days. Currently, 1.0% of the shares of the company are sold short.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on BKYI shares. Weiss Ratings restated a “sell (e+)” rating on shares of BIO-key International in a research report on Friday, July 17th. Zacks Research upgraded BIO-key International to a “hold” rating in a research report on Thursday, August 6th. One equities research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Reduce”.

BIO-key International Trading Up 4.7%

Shares of BKYI stock traded up $0.14 during trading hours on Thursday, reaching $3.10. The company’s stock had a trading volume of 41,722 shares, compared to its average volume of 159,880. The firm’s fifty day simple moving average is $4.18 and its 200 day simple moving average is $5.02. The stock has a market capitalization of $4.46 million, a P/E ratio of -0.75 and a beta of 0.44. BIO-key International has a one year low of $2.88 and a one year high of $19.70.

BIO-key International (NASDAQ:BKYI) last issued its quarterly earnings data on Thursday, August 13th. The technology company reported ($0.56) EPS for the quarter, topping the consensus estimate of ($0.82) by $0.26. BIO-key International had a negative net margin of 50.01% and a negative return on equity of 67.31%. The business had revenue of $1.92 million during the quarter, compared to analyst estimates of $1.80 million. As a group, equities research analysts forecast that BIO-key International will post -1.62 earnings per share for the current fiscal year.

Institutional Trading of BIO-key International

A hedge fund recently raised its stake in BIO-key International stock. Geode Capital Management LLC boosted its position in shares of BIO-key International Inc. (NASDAQ:BKYI) by 49.9% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 48,892 shares of the technology company’s stock after purchasing an additional 16,271 shares during the quarter. Geode Capital Management LLC owned about 0.45% of BIO-key International worth $26,000 at the end of the most recent reporting period. 26.51% of the stock is currently owned by hedge funds and other institutional investors.

BIO-key International Company Profile

BIO-key International, Inc is a developer and provider of fingerprint biometric identity and access management solutions, serving enterprise and government customers. The company’s core offerings include a range of fingerprint readers and authentication software designed to verify user identity across physical and digital environments. By leveraging proprietary template-on-card and template-on-device technologies, BIO-key seeks to enhance security and streamline user access without reliance on traditional passwords.

In addition to hardware sensors, BIO-key delivers software platforms that integrate with existing IT infrastructures such as Microsoft Active Directory and major workforce management systems.